MedPath

TALKHA CENTRAL HOSPITAL

🇪🇬Egypt
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

1 Phases

Phase 4:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 4
2 (100.0%)

Education and Social Media Versus Non-Indicated Caesarean Section Rate in Egypt

Completed
Conditions
Complications; Cesarean Section
First Posted Date
2016-05-27
Last Posted Date
2016-09-07
Lead Sponsor
Talkha Central Hospital
Target Recruit Count
1400
Registration Number
NCT02785094
Locations
🇪🇬

Talkha Central Hospital, Mansoura, Al-Dakahliya, Egypt

Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section

Phase 4
Completed
Conditions
Hemorrhage of Cesarean Section and/or Perineal Wound
Postpartum Hemorrhage
Uterine Atony
Interventions
Procedure: Intraoperative Uterine Cooling
First Posted Date
2016-05-23
Last Posted Date
2016-09-05
Lead Sponsor
Talkha Central Hospital
Target Recruit Count
100
Registration Number
NCT02780245
Locations
🇪🇬

Talkha Central Hospital, Mansoura, Al-Dakahliya, Egypt

Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section

Phase 4
Completed
Conditions
Hemorrhage of Cesarean Section and/or Perineal Wound
Postpartum Hemorrhage
Interventions
Drug: Normal Saline containing a prophylactic Antibiotic 1 g
First Posted Date
2016-04-15
Last Posted Date
2016-06-15
Lead Sponsor
Talkha Central Hospital
Target Recruit Count
200
Registration Number
NCT02739815
Locations
🇪🇬

Al-Azhar University, Faculty of Medicine for Boys ( Cairo ), Al-Hussein University Hospital, Cairo, Egypt

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.